Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 1, 2014, Pages 87-95

  Monteiro, Ana Paula T ^a   Soledade, Erico ^b   Pinheiro, Carla S ^a   Dellatorre Teixeira, Ludmilla ^a   Oliveira, Gisele P ^a   Oliveira, Mariana G ^a   Peters Golden, Marc ^a   Rocco, Patricia R M ^a   Benjamim, Claudia F ^b   Canetti, Claudio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

5 lipoxygenase; Cytokines; Leukotrienes; Lung injury; Sepsis

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CXCL1 CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; LUNG FUNCTION; LUNG INJURY; LUNG PARENCHYMA; LUNG STRUCTURE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; SEPSIS; SYNTHESIS; WILD TYPE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CECUM; CYTOKINES; INFLAMMATION; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; LUNG INJURY; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; RECEPTORS, LEUKOTRIENE; RECEPTORS, LEUKOTRIENE B4; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84891790430     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0525OC     Document Type: Article

References (45)

1. O'Brien JM Jr, Ali NA, Aberegg SK, Abraham E. Sepsis. Am J Med 2007; 120: 1012-1022. (Pubitemid 350166215)
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310. (Pubitemid 32641789)
3. Lichtenstern C, Brenner T, Bardenheuer HJ, Weigand MA. Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr Opin Infect Dis 2012; 25: 328-336.
4. Sadowitz B, Roy S, Gatto LA, Habashi N, Nieman G. Lung injury induced by sepsis: lessons learned from large animal models and future directions for treatment. Expert Rev Anti Infect Ther 2011; 9: 1169-1178.
5. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645-655. (Pubitemid 20280195)
6. Peters-Golden M, Coffey M. Role of leukotrienes in antimicrobial defense of the lung. J Lab Clin Med 1998; 132: 251-257. (Pubitemid 28490257)
7. Bailie MB, Standiford TJ, Laichalk LL, Coffey MJ, Strieter R, Peters- Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 1996; 157: 5221-5224. (Pubitemid 126448936)
8. Benjamim CF, Canetti C, Cunha FQ, Kunkel SL, Peters-Golden M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J Immunol 2005; 174: 1616-1620.
9. Ishizaka A, Hasegawa N, Sakamaki F, Tasaka S, Nakamura H, Kishikawa K, Yamada A, Obata T, Sayama K, Urano T, et al. Effects of ONO- 1078, a peptide leukotriene antagonist, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med 1994; 150: 1325-1331.
10. Yoshimura K, Nakagawa S, Koyama S, Kobayashi T, Homma T. Roles of neutrophil elastase and superoxide anion in leukotriene B4- induced lung injury in rabbit. J Appl Physiol 1994; 76: 91-96. (Pubitemid 24048231)
11. Phillips GJ, Mohammed W, Kelly FJ. Oxygen-induced lung injury in the pre-term guinea pig: the role of leukotriene B4. Respir Med 1995; 89: 607-613.
12. VanderMeer TJ, Menconi MJ, O'Sullivan BP, Larkin VA, Wang H, Sofia M, Fink MP. Acute lung injury in endotoxemic pigs: role of leukotriene B4. J Appl Physiol 1995; 78: 1121-1131.
13. Furue S, Kuwabara K, Mikawa K, Nishina K, Shiga M, Maekawa N, Ueno M, Chikazawa Y, Ono T, Hori Y, et al. Crucial role of group IIA phospholipase A(2) in oleic acid-induced acute lung injury in rabbits. Am J Respir Crit Care Med 1999; 160: 1292-1302. (Pubitemid 29487473)
14. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94: 331-335. (Pubitemid 13043132)
15. Ornellas DS, Maron-Gutierrez T, Ornellas FM, Cruz FF, Oliveira GP, Lucas IH, Fujisaki L, Oliveira MG, Teodoro WR, Capelozzi VL, et al. Early and late effects of bone marrow-derived mononuclear cell therapy on lung and distal organs in experimental sepsis. Respir Physiol Neurobiol 2011; 178: 304-314.
16. Bates JH, Ludwig MS, Sly PD, Brown K, Martin JG, Fredberg JJ. Interrupter resistance elucidated by alveolar pressure measurement in open-chest normal dogs. J Appl Physiol 1988; 65: 408-414.
17. Hsia CC, Hyde DM, Ochs M, Weibel ER. How to measure lung structure - what for? On the "Standards for the quantitative assessment of lung structure." Respir Physiol Neurobiol 2010; 171: 72-74.
18. Rocco PR, Negri EM, Kurtz PM, Vasconcellos FP, Silva GH, Capelozzi VL, Romero PV, Zin WA. Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. Am J Respir Crit Care Med 2001; 164: 1067-1071. (Pubitemid 32971660)
19. Moreno SE, Alves-Filho JC, Bertozi G, Alfaya TM, Thèze J, Ferreira SH, Vargaftig BB. Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: role of nitric oxide. Br J Pharmacol 2006; 148: 1060-1066. (Pubitemid 44223011)
20. Remick DG, Larrick JW, Nguyen DT, Kunkel SL. Stimulation of prostaglandin E2 and thromboxane B2 production by human monocytes in response to interleukin-2. Biochem Biophys Res Commun 1987; 147: 86-93. (Pubitemid 17151956)
21. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL. Endogenous monocyte chemoattractant protein-1 (MCP- 1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol 1999; 163: 6148-6154.
22. Canetti C, Silva JS, Ferreira SH, Cunha FQ. Tumour necrosis factoralpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation. Br J Pharmacol 2001; 134: 1619-1628. (Pubitemid 34038094)
23. Ramos CD, Canetti C, Souto JT, Silva JS, Hogaboam CM, Ferreira SH, Cunha FQ. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J Leukoc Biol 2005; 78: 167-177. (Pubitemid 40979955)
24. Oliveira SH, Canetti C, Ribeiro RA, Cunha FQ. Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation 2008; 31: 36-46. (Pubitemid 351246254)
25. Rocco PR, Zin WA. Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different? Curr Opin Crit Care 2005; 11: 10-17. (Pubitemid 40223714)
26. Ichinose F, Zapol WM, Sapirstein A, Ullrich R, Tager AM, Coggins K, Jones R, Bloch KD. Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice. Circ Res 2001; 88: 832-838. (Pubitemid 32429980)
27. Bitto A, Minutoli L, David A, Irrera N, Rinaldi M, Venuti FS, Squadrito F, Altavilla D. Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis. Crit Care 2012; 16: R32-R43.
28. Cybulsky MI, McComb DJ, Movat HZ. Neutrophil leukocyte emigration induced by endotoxin: mediator roles of interleukin 1 and tumor necrosis factor alpha 1. J Immunol 1988; 140: 3144-3149.
29. Watanabe K, Konishi K, Fujioka M, Kinoshita S, Nakagawa H. The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem 1989; 264: 19559-19563. (Pubitemid 20008058)
30. Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Fredenburgh L, Massaro AF, Rogers A, Gazourian L, Nakahira K, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 2012; 185: 1225-1234.
31. von Moltke J, Trinidad NJ, Moayeri M, Kintzer AF, Wang SB, van Rooijen N, Brown CR, Krantz BA, Leppla SH, Gronert K, et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 2012; 490: 107-111.
32. Anderson AC, Reddy J, Nazareno R, Sobel RA, Nicholson LB, Kuchroo VK. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J Immunol 2004; 173: 828-834. (Pubitemid 38924257)
33. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-3451.
34. Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, Powrie F, Maloy KJ. IL-1b mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(1) Th17 cells. J Exp Med 2012; 209: 1595-1609.
35. Besnard AG, Togbe D, Couillin I, Tan Z, Zheng SG, Erard F, Le Bert M, Quesniaux V, Ryffel B. Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol 2012; 4: 3-10.
36. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485-498.
37. Griffin GK, Newton G, Tarrio ML, Bu DX, Maganto-Garcia E, Azcutia V, Alcaide P, Grabie N, Luscinskas FW, Croce KJ, et al. IL-17 and TNF-a sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 2012; 188: 6287-6299.
38. Freitas A, Alves-Filho JC, Victoni T, Secher T, Lemos HP, Sônego F, Cunha FQ, Ryffel B. IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol 2009; 182: 7846-7854.
39. Arraes SM, Freitas MS, da Silva SV, de Paula Neto HA, Alves-Filho JC, Auxiliadora Martins M, Basile-Filho A, Tavares-Murta BM, Barja- Fidalgo C, Cunha FQ. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006; 108: 2906-2913.
40. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD41 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132. (Pubitemid 41541790)
41. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141. (Pubitemid 41541791)
42. Schwarzenberger P, Kolls JK. Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis. J Cell Biochem Suppl 2002; 38: 88-95. (Pubitemid 34477671)
43. Laan M, Cui ZH, Hoshino H, Lötvall J, Sjöstrand M, Gruenert DC, Skoogh BE, Lindén A. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162: 2347-2352. (Pubitemid 29288861)
44. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, Polubinska A, Friess H, Gahl GM, Frei U, et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000; 165: 5814-5821.
45. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194: 519-527. (Pubitemid 32835046)